Engineered strain of
Methods and systems for producing prescribed unit size poly(3-hydroxyalkanoate) (PHA) polymers and copolymers are provided. The methods and systems can employ recombinant bacteria that are not native producers of PHA or lack enzymes to degrade PHA once synthesized, metabolize short to long chain fatty acids without induction, and express an (R)-specific enoyl-CoA hydratase and a PHA synthase, the (R)-specific enoyl-CoA hydratase and PHA synthase having wide substrate specificities. The recombinant bacteria are fed at least one fatty acid substrate that is equal in carbon length to the prescribed or desired unit size of the PHA polymer to be produced. The prescribed unit size PHA that is produced is then isolated and/or purified.
1. A recombinant bacterium for producing a prescribed unit size of a poly(3-hydroxyalkanoate) (PHA) polymer, wherein the bacterium:
metabolizes a short to long chain fatty acid substrate without induction,
deletes the gene for the (S)-specific enoyl-CoA hydratase (fadB) and the gene fadJ (also known as yfcX) which is involved in the β-oxidation pathway;
expresses an (R)-specific enoyl-CoA hydratase and a PHA synthase, and
produces exclusively a prescribed unit size PHA polymer from a fatty acid substrate, the fatty acid substrate being of equal carbon length to the prescribed unit size of the PHA polymer to be produced.
2. The recombinant bacterium of claim 1 , wherein the bacterium is not a native or natural producer of PHA or lacks enzymes to degrade PHA once synthesized.
3. The recombinant bacterium of claim 1 , wherein the recombinant bacterium is a recombinant E. coli.
4. The recombinant bacterium of claim 1 , wherein the bacterium comprises a plasmid comprising an (R)-specific enoyl-CoA hydratase gene and a PHA synthase gene.
5. The recombinant bacterium of claim 1 , wherein β-oxidation is blocked in the recombinant bacterium.
6. The recombinant bacterium of claim 1 , wherein at least one gene encoding an enzyme for β-oxidation is inactive or deleted from the chromosome of the recombinant bacterium.
7. The recombinant bacterium of claim 1 , wherein the recombinant bacterium constitutively expresses a positive regulator of an operon, wherein the operon promotes uptake of short chain fatty acids for β-oxidation.
8. The recombinant bacterium of claim 3 , wherein the recombinant E. coli constitutively expresses AtoC.
9. The recombinant bacterium of claim 1 , wherein the recombinant bacterium expresses propionyl-CoA transferase (PCT).
10. The recombinant bacterium of claim 1 , wherein the recombinant bacterium has gene deletions for a negative transcriptional regulator of the β-oxidation pathway.